Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery

NCT00025181 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Intraocular Melanoma
Melanoma (Skin)

Interventions

BIOLOGICAL: MART-1 antigen
BIOLOGICAL: gp100 antigen
BIOLOGICAL: incomplete Freund's adjuvant
BIOLOGICAL: ipilimumab
BIOLOGICAL: tyrosinase peptide
PROCEDURE: adjuvant therapy

Sponsor

University of Southern California

Collaborators

[object Object]